The global epigenetics market was valued at USD 19.1 billion in 2025 and is projected to grow from USD 21.9 billion in 2026 to USD 63.2 billion by 2033, expanding at a CAGR of 16.4% from 2026 to 2033. North America dominated the market in 2025, accounting for 38.7% of global revenue. The market is experiencing strong growth as epigenetic technologies become increasingly important for...